Verda Arshad
Mayo Clinic
Survival analysisInternal medicineSurgeryLead (electronics)Retrospective cohort studyMinimum inhibitory concentrationMortality rateMedical microbiologySeptic arthritisVegetation (pathology)Methicillin-resistant Staphylococcus aureusVancomycinInfective endocarditisDevice removalSignificant differenceRe implantationLength of hospitalizationMedicineComplication
2Publications
0Citations
Publications 3
Newest
#1Khawaja M Talha (Mayo Clinic)H-Index: 2
#2Larry M. Baddour (Mayo Clinic)H-Index: 90
Last. Raj Palraj (Mayo Clinic)H-Index: 2
view all 0 authors...
Abstract null null Background null : The purpose of the study was to assess the epidemiology, risk factors and outcomes of native vertebral osteomyelitis (NVO) in patients with Staphylococcus aureus bacteremia (SAB). null null null Methods null : A retrospective institutional review was conducted at Mayo Clinic, Minnesota. Patients aged ≥ 18 years with SAB who developed NVO from January 1, 2006 to December 31, 2020 were included and 3-month follow-up data were abstracted. Data pertaining to pati...
Source
#1Verda Arshad (Mayo Clinic)
#2Larry M. Baddour (Mayo Clinic)H-Index: 90
Last. M. Rizwan Sohail (BCM: Baylor College of Medicine)H-Index: 20
view all 9 authors...
BACKGROUND Optimal timing of cardiovascular implantable electronic device (CIED) re-implantation following device removal due to infection is undefined. Multinational guidelines reflect this and include no specific recommendation for this timing, while others have recommended waiting at least 14 days in cases of CIED related infective endocarditis (CIED-IE). The current work seeks to clarify this issue. METHODS We retrospectively reviewed institutional data at Mayo Clinic, Minnesota of patients ...
Source
#1Khawaja M Talha (Mayo Clinic)H-Index: 2
#2Hassan Ishaq (Mayo Clinic)H-Index: 1
Last. Raj Palraj (Mayo Clinic)H-Index: 2
view all 8 authors...
The purpose of this study is to determine the role of high (≥ 1.5 mg/L) vancomycin minimum inhibitory concentration (VMIC) in predicting clinical outcomes in patients with methicillin-resistant Staphylococcus aureus bacteraemia (MRSAB). A retrospective study was conducted at Mayo Clinic, Minnesota. Patients ≥ 18 years with a 3-month follow-up were included. Outcomes were defined as 30-day all-cause in-hospital mortality, median duration of bacteraemia, metastatic infectious complications, and re...
Source